Healthcare & Life Sciences

Syndeavor Therapeutics

Syndeavor Therapeutics is a Healthcare & Life Sciences startup based in the United States.

About Syndeavor Therapeutics

Based in the United States, Syndeavor Therapeutics is a startup. Brouky classifies it under Healthcare & Life Sciences.

Syndeavor Therapeutics is developing a small molecule inhibitor of ACSS2 for the treatment of triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC).

Explore Syndeavor Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States